Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund , 44227 Dortmund, Germany.
Pharmazeutisches Institut, Pharmazeutische Chemie II, Universität Bonn , 53121 Bonn, Germany.
J Org Chem. 2017 Oct 6;82(19):10504-10522. doi: 10.1021/acs.joc.7b02012. Epub 2017 Sep 26.
The synthesis of the A-B-cis,B-C-trans-annulated cyclohepta[e]hydrindane core of a gagunin E analogue is reported in detail. The tricarbocyclic scaffold was assembled starting from an easily accessible A ring building block by a (4 + 2)-cycloaddition for annulation of the B ring. A ring-closing metathesis served for construction of the seven-membered C ring. The angular methyl groups were attached by electrophilic cyclopropanation-ring opening. A library based on the most active lead compound was made accessible by esterification of the terpenols with commercially available acids. A transannular etherification reaction gave access to tetracyclic derivatives of the synthetic inhibitors. The members of the compound library of non-natural homoverrucosanoid-derived esters were examined as modulators of the membrane transporter proteins ABCB1 (P-gp), ABCG2 (BCRP), and ABCC1 (MRP1), which are involved in the formation of multidrug resistance (MDR) in cancer chemotherapy.
详细报告了一种 gagunin E 类似物的 A-B-cis,B-C-trans-稠合环己[e]六氢茚核心的合成。三环骨架是从一个容易获得的 A 环构建块开始,通过(4 + 2)-环加成反应来环合 B 环。通过环 closing 复分解反应构建了七元 C 环。通过亲电环丙烷开环反应将角甲基基团连接起来。通过用市售酸酯化萜醇,可获得基于最有效先导化合物的文库。反式环醚化反应可获得合成抑制剂的四环衍生物。非天然 homoverrucosanoid 衍生酯的化合物库成员被用作 ABCB1(P-gp)、ABCG2(BCRP)和 ABCC1(MRP1)膜转运蛋白调节剂的研究,这些蛋白参与癌症化疗中多药耐药(MDR)的形成。